Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy-Reference-Cited by-同舟云学术

Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy

Published:2020-05-27 Issue:10 Volume:146 Page:2659-2668
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Hakozaki Taiki,Hosomi Yukio^ORCID,Shimizu Akihiro,Kitadai Rui,Mirokuji Kie,Okuma Yusuke

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-020-03252-4.pdf

Reference36 articles.

1. American Geriatrics Society Beers Criteria Update Expert P (2012) American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60(4):616–631

2. Bigot F, Castanon E, Baldini C, Hollebecque A, Carmona A, Postel-Vinay S et al (2017) Prospective validation of a prognostic score for patients in immunotherapy phase I trials: the Gustave Roussy Immune Score (GRIm-Score). Eur J Cancer 84:212–218

3. By the American Geriatrics Society Beers Criteria Update Expert P (2015) American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 63(11):2227–2246

4. Cashman J, Wright J, Ring A (2010) The treatment of co-morbidities in older patients with metastatic cancer. Support Care Cancer 18(5):651–655

5. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of polypharmacy on the outcomes of older patients with advanced non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors: A retrospective cohort study;Journal of Geriatric Oncology;2024-09

2. Association of potentially inappropriate medications with prognosis among older patients with non-small cell lung cancer;BMC Geriatrics;2024-06-25

3. Toxicity in Older Patients with Cancer Receiving Immunotherapy: An Observational Study;Drugs & Aging;2024-05

4. Anlotinib in Chinese patients aged ≥70 years with advanced non-squamous non-small cell lung cancer without prior chemotherapy: a multicenter, single-arm pilot trial;Frontiers in Oncology;2024-04-08

5. Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes;Lung Cancer;2023-09